ID: ALA3882743
Type: Binding
Description: Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method
Format: BAO_0000357
Organism: Homo sapiens
Target: Serine/threonine-protein kinase Chk2(ALA2527)
Document: ALA3882723
Inhibition of human CDS1 using N-terminal biotin labeled SGLYRSPSMPENLNRPR as substrate in presence of [gamma-33P]-ATP after 3 hrs by scintillation counting method: 38
Bioactivity
Activity Types for Assay ALA3882743
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
297.31 | 1.70 | 1.70 |
311.34 | 2.09 | 2.09 |
337.38 | 2.62 | 2.62 |
351.41 | 3.01 | 3.01 |
336.40 | 2.41 | 2.41 |
412.49 | 3.98 | 3.98 |
364.45 | 3.19 | 3.19 |
336.40 | 2.46 | 2.46 |
338.41 | 2.66 | 2.66 |
378.48 | 3.58 | 3.58 |
336.40 | 2.46 | 2.46 |
350.42 | 2.80 | 2.80 |
350.42 | 2.71 | 2.71 |
350.42 | 2.71 | 2.71 |
440.55 | 4.62 | 4.62 |
454.57 | 4.93 | 4.93 |
470.57 | 4.63 | 4.63 |
474.99 | 5.27 | 5.27 |
509.44 | 5.93 | 5.93 |
440.55 | 4.62 | 4.62 |
454.57 | 4.93 | 4.93 |
470.57 | 4.63 | 4.63 |
474.99 | 5.27 | 5.27 |
509.44 | 5.93 | 5.93 |
454.57 | 5.15 | 5.15 |
468.60 | 5.46 | 5.46 |
484.60 | 5.16 | 5.16 |
489.02 | 5.81 | 5.81 |
523.46 | 6.46 | 6.46 |
454.57 | 5.01 | 5.01 |
468.60 | 5.32 | 5.32 |
484.60 | 5.02 | 5.02 |
489.02 | 5.66 | 5.66 |
523.46 | 6.32 | 6.32 |
454.53 | 4.26 | 4.26 |
468.56 | 4.79 | 4.79 |
468.56 | 4.65 | 4.65 |
378.43 | 2.72 | 2.72 |
392.46 | 2.97 | 2.97 |
392.46 | 2.97 | 2.97 |
406.49 | 3.50 | 3.50 |
406.49 | 3.36 | 3.36 |
364.45 | 3.24 | 3.24 |
450.54 | 4.35 | 4.35 |
338.41 | 2.66 | 2.66 |
464.57 | 4.89 | 4.89 |
378.43 | 2.72 | 2.72 |
365.43 | 3.26 | 3.26 |
460.97 | 5.03 | 5.03 |
364.45 | 3.10 | 3.10 |
426.52 | 4.37 | 4.37 |
426.52 | 4.37 | 4.37 |
436.51 | 4.11 | 4.11 |
365.43 | 3.26 | 3.26 |
436.51 | 4.11 | 4.11 |
464.57 | 4.74 | 4.74 |
450.54 | 4.35 | 4.35 |